Korean J Radiol.  2006 Mar;7(1):57-69. 10.3348/kjr.2006.7.1.57.

False Positive and False Negative FDG-PET Scans in Various Thoracic Diseases

• Chang JM
• Lee HJ
• Goo JM
• Lee HY
• Lee JJ
• Chung JK
• Im JG

• KMID: 753917
• DOI: http://doi.org/10.3348/kjr.2006.7.1.57

Abstract

Fluorodeoxyglucose (FDG)-positron emission tomography (PET) is being used more and more to differentiate benign from malignant focal lesions and it has been shown to be more efficacious than conventional chest computed tomography (CT). However, FDG is not a cancer-specific agent, and false positive findings in benign diseases have been reported. Infectious diseases (mycobacterial, fungal, bacterial infection), sarcoidosis, radiation pneumonitis and post-operative surgical conditions have shown intense uptake on PET scan. On the other hand, tumors with low glycolytic activity such as adenomas, bronchioloalveolar carcinomas, carcinoid tumors, low grade lymphomas and small sized tumors have revealed false negative findings on PET scan. Furthermore, in diseases located near the physiologic uptake sites (heart, bladder, kidney, and liver), FDG-PET should be complemented with other imaging modalities to confirm results and to minimize false negative findings. Familiarity with these false positive and negative findings will help radiologists interpret PET scans more accurately and also will help to determine the significance of the findings. In this review, we illustrate false positive and negative findings of PET scan in a variety of diseases.

Keyword

Computed tomography (CT); Positron emmosion tomography (PET); Thoracic diseases

MeSH Terms

Tuberculoma/diagnosis
Thoracic Diseases/*diagnosis
Radiopharmaceuticals/*diagnostic use
*Positron-Emission Tomography
Paragonimiasis/diagnosis
Lymphatic Diseases/diagnosis
Lung Diseases/*diagnosis
Hyperglycemia/diagnosis
Humans
Histiocytoma, Benign Fibrous/diagnosis
Fluorodeoxyglucose F18/*diagnostic use
False Positive Reactions
False Negative Reactions
Diagnosis, Differential
Cryptococcosis/diagnosis

Figure

• 

  Fig. 1 Normal distribution of FDG. Coronal FDG-PET image shows physiologic uptake in the liver, kidneys, intestine, and urinary bladder. Also note the minimal uptake in the mediastinum, and bone marrow.

• 

  Fig. 2 Normal increased FDG uptake in the shoulder area which represents brown fat.

• 

  Fig. 3 Tuberculoma in a 53-year-old female. A. Contrast-enhanced CT scan shows a round mass in the left lower lobe. B. Axial FDG-PET image shows intense uptake (arrow) in the left upper lobe suggesting a malignant condition with a maximum standardized uptake value of 4.3. The pathologic examination reveals tuberculoma. Another lesion showing high FDG uptake (arrowhead) is a pulmonary artery.

• 

  Fig. 4 Tuberculous lymphadenitis in a 56-year-old male. A. Axial contrast-enhanced CT scan shows right hilar lymph node enlargement (arrow). B. Coronal FDG-PET scan shows high uptake in the same area (arrow).

• 

  Fig. 5 Sarcoidosis in a 32-year-old male. A. Axial PET-CT scans show bilateral paratracheal and hilar lymph node enlargement with high FDG uptake. B. Coronal section of PET shows high FDG uptake with rhamda shape (arrowheads) which is highly suggestive of sarcoidosis. A mediastinoscopic biopsy confirms sarcoidosis.

• 

  Fig. 6 Cryptococcosis in a 68-year-old female. A. Contrast-enhanced CT scan shows a cavitary nodule (arrow) in the left lower lobe. B. Transverse section of a whole body PET image shows increased uptake (arrow) in the left lower lobe and a standardized uptake value of 2.6. The lesion is a round mass-like lesion unlike the CT findings due to respiration artifact.

• 

  Fig. 7 Paragonimiasis in a 68-year-old male. A. In the lung window setting, axial transverse CT scan shows linear, wedge shaped consolidation and small centrilobular nodules. Radiologic diagnosis is atypical tuberculosis. B. Coronal section of FDG-PET image shows intense uptake in the right lower lung zone. Bronchoscopic washing and sputum cytology reveals many parasitic eggs of paragonimus species.

• 

  Fig. 8 Lung abscess in a 72-year-old male. A. Axial contrast enhanced CT scans show a consolidation with air density in the right upper lobe (black arrow). Multiple conglomerated mediastinal lymph node enlargements are also noted (white arrow). B. Coronal FDG-PET image shows high uptake (arrows) in the right upper lobe. High uptake in the left hilar lymph node (arrowhead) is also noted. Malignancy is suspected in PET scan. Percutaneous needle biopsy reveals a lung abscess.

• 

  Fig. 9 Pneumocystis carinii infection in a 61-year-old female. A. In the lung window setting of chest CT, multifocal ground-glass opacities are noted. The patient had been diagnosed with systemic lupus erythematosus, and cytoxan and steroid pulse therapy was performed. B. PET-CT shows multifocal hypermetabolic lesions with an standardized uptake value of between 4.0-5.8 in both lung parenchymas.

• 

  Fig. 10 Radiation fibrosis in a 61-year-old male by radiation therapy due to lung cancer. A. Axial CT scan shows consolidation in the left lower lobe, suggesting lung cancer recurrence. B. Axial PET image shows increased uptake in the left lower lobe (arrow) which was mistaken for lung cancer recurrence. C. Microscopic image reveals severe fibrosis with inflammatory cell accumulation.

• 

  Fig. 11 Progressive massive fibrosis in a 58-year-old male. Coronal FDG-PET image shows increased uptake in right upper lobe (arrow) and a mean standardized uptake value of 6.4.

• 

  Fig. 12 Sclerosing hemangioma in a 43-year-old female. A. Axial contrast-enhanced CT shows a round well demarcated, highly enhancing mass in the right lateral side of the superior vena cava in the right upper lobe. B. FDG-PET fusion CT image shows increased uptake in the lesion with a maximum standardized uptake value of 3.4.

• 

  Fig. 13 Bronchioloalveolar carcinoma in a 75-year-old male. A. Contrast-enhanced CT shows a cavitary lesion in the left lower lobe (arrow). B. Transverse FDG-PET image of the transverse scan shows subtle uptake (arrow) in the left lower lobe with a maximum standardized uptake value of 1.7.

• 

  Fig. 14 Mucinous bronchioloalveolar carcinoma in a 61-year-old female. A, B. Axial chest CT images show a low attenuating mass in the left upper lobe. C. FDG-PET also shows a hypermetabolic lesion with a maximum standardized uptake value of 3.8 in the left upper lobe. D. Another area of ground-glass opacity is noted in the right lower lobe. E. FDG-PET shows no abnormal uptake in this area. Both the left upper and right lower lobe lesions were bronchioloalveolar carcinomas, mucinous type. In the same patient, FDG uptake for each of the lung lesions was different, and the amount mucin in mass may have been the major cause of this difference.

• 

  Fig. 15 Small malignant mediastinal lymph node in a 56-year-old male. A. Axial contrast-enhanced CT shows a nodular lesion in the right upper lobe with a lymph node of less than 1 cm in the right paratracheal area (arrow). B. FDG-PET fusion CT shows no increased uptake due to the small size of the lesion (arrow). C. Pathology reveals a 0.6 cm lymph node with metastatic tumor cells.

• 

  Fig. 16 Metastatic lung nodule from mucinous carcinoma of the left breast. A. Gadolinium-enhanded MR shows a well enhancing lobulating mass. B. FDG-PET fusion CT shows a nodular lesion in the right lower lung without increased FDG uptake (arrow).

• 

  Fig. 17 Metastasis from renal cell carcinoma in an 83-year-old male. A. Axial contrast-enhanced CT scans shows a mass lesion in the right kidney suggesting renal cell carcinoma. B. Axial CT scan of lung window setting shows a lung nodule in the right middle lobe (arrow). C. A selected transverse section of whole body-PET image shows no demonstrable uptake in the right lung.

• 

  Fig. 18 Post-chemotherapy related decreased lymph node uptake in a 57-year-old male lung cancer patient. A. Pre-chemotherapy FDG-PET fusion CT shows increased FDG uptake in the subcarinal lymph node with a maximum standardized uptake value of 9.4. B. After two months of chemotherapy, the residual lesion in the subcarinal area is noted. C. FDG-PET fusion CT shows no abnormal FDG uptake.

Reference

1. Goo JM, Im JG, Do KH, Yeo JS, Seo JB, Kim HY, et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology. 2000. 216:117–121.

2. Kostakoglu L, Agress H, Goldsmith SJ. Clinical role of FDG PET in evalutaion of cancer patients. RadioGraphics. 2003. 23:315–340.

3. Trukington TG, Coleman RE. Clinical oncologic PET: An Introduction. Semin Roentgenol. 2002. 37:102–109.

4. Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (< 1 cm), intermediate (1 to 3 cm), and large (> 3 cm) lymph node lesions. Chest. 2000. 117:773–778.

5. Alavi A, Gupta N, Alberini JL, Hickeson M, Adam LE, Bhargava P, et al. Positron emission tomography Imaging in nonmalignant thoracic disorders. Semin Nucl Med. 2002. 32:293–321.

6. Amerein PC, Larson SM, Wagner HN Jr. An automated system for measurement of leukocyte metabolism. J Nucl Med. 1974. 15:352–355.

7. Crystal RG . Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Disorders of the immune system, connective tissue, and joints, sarcoidosis. Harrison's principle of internal medicine. 2001. 15th ed. NewYork: McGraw-Hill;1969–1970.

8. Bakheet SM, Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med. 1998. 28:352–358.

9. Brudin LH, Valind SO, Rhodes CG, Pantin CF, Sweatman M, Jones T, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med. 1994. 21:297–305.

10. Bennett JE. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Cryptococcosis. H arrison's principle of internal medicine. 2001. 15th ed. NewYork: McGraw-Hill;1174–1175.

11. Watanabe S, Nakamura Y, Kariatsumari K, Nagata T, Sakata R, Zinnouchi S, et al. Pulmonary paragonimiasis mimicking lung cancer on FDG-PET imaging. Anticancer Res. 2003. 23:3437–3440.

12. Im JG, Kong Y, Shin YM, Yang SO, Song JG, Han MC, et al. Pulmonary paragonimiasis: clinical and experimental studies. RadioGraphics. 1993. 13:575–586.

13. Lorenzen J, Buchert R, Bleckmann C, Munchow N, Bohuslavizki KH. A search for the focus in patients with fever of unknown origin: is positron-emission tomography with F-18-fluorodeoxyglucose helpful? Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 1999. 171:49–53.

14. Lin P, Chu J, Pocock N. Fluorine-18 FDG dual-head gamma camera coincidence imaging of radiation pneumonitis. Clin Nucl Med. 2000. 25:866–869.

15. Speizer FE. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Environmental lung diseases. Principle of internal medicine. 2001. 15th ed. NewYork: McGraw-Hill;1470–1471.

16. Hara M, Iida A, Tohyama J, Miura N, Shiraki N, Itoh M, et al. FDG-PET findings in sclerosing hemangioma of the lung: a case report. Radiat Med. 2001. 19:215–218.

17. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992. 33:1972–1980.

18. Kim B, Kim Y, Lee K, Yoon SB, Cheon EM, Kwon OJ, et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR Am J Roentgenol. 1998. 170:935–939.

19. Berger KL, Nicholson SA, Dehdashti F, Siegel BA. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol. 2000. 174:1005–1008.

20. Montravers F, Grahek D, Kerrou K, Younsi N, Doublet JD, Gattegno B, et al. Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera. J Nucl Med. 2000. 41:78–84.

21. Avril N, Rose CA, Schelling M, Dose J, Kuhn W, Bense S, et al. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxtglucose: use and limitations. J Clin Oncol. 2000. 18:3495–3502.

22. Ryu JS, Choi NC, Fischman AJ, Lynch TJ, Mathisen DJ. FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology. Lung Cancer. 2002. 35:179–187.

23. Erasmus JJ, McAdams HP, Patz EF Jr, Coleman RE, Ahuja V, Goodman PC. Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR Am J Roentgenol. 2004. 182:559–567.